PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9972388-1	1999	OBJECTIVE: To review published literature investigating the efficacy and safety of levodopa in the management of restless legs syndrome (RLS), with emphasis on the hemodialysis population.	Levodopa	83-91	RLS1	Homo sapiens	137-140	
9972388-4	1999	STUDY SELECTION AND DATA EXTRACTION: All identified human studies investigating the use of levodopa for the management of RLS in uremic and nonuremic patients were analyzed.	Levodopa	91-99	RLS1	Homo sapiens	122-125	
9972388-6	1999	Although the benefits of levodopa/(carbidopa/benserazide) in reducing the signs and symptoms of RLS are documented in nonuremic patients, evidence in patients with ESRD is less readily available.	Levodopa	25-33	RLS1	Homo sapiens	96-99	
9972388-8	1999	CONCLUSIONS: In general, the small amount of published literature supports the empirical use of levodopa/carbidopa as a safe and effective therapy to manage the distressing symptoms of RLS in a hemodialysis population.	Levodopa	96-104	RLS1	Homo sapiens	185-188